CRIS Current Research Information System

MANZOLI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.096
AS - Asia 9.617
EU - Europa 8.192
AF - Africa 769
SA - Sud America 554
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 3
Totale 29.257
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.915
SG - Singapore 2.699
IT - Italia 2.650
CN - Cina 2.365
VN - Vietnam 2.318
GB - Regno Unito 1.275
DE - Germania 994
SE - Svezia 920
HK - Hong Kong 599
FR - Francia 408
BR - Brasile 385
IN - India 371
RU - Federazione Russa 324
NL - Olanda 317
KR - Corea 309
JP - Giappone 221
UA - Ucraina 208
IE - Irlanda 207
BD - Bangladesh 196
TG - Togo 194
FI - Finlandia 190
SC - Seychelles 161
CI - Costa d'Avorio 140
ZA - Sudafrica 140
CA - Canada 116
AT - Austria 105
CH - Svizzera 99
BG - Bulgaria 88
EE - Estonia 88
HR - Croazia 86
AR - Argentina 80
JO - Giordania 68
NG - Nigeria 68
ID - Indonesia 62
PH - Filippine 62
BE - Belgio 61
TH - Thailandia 58
TR - Turchia 45
PL - Polonia 40
PK - Pakistan 38
ES - Italia 32
IQ - Iraq 30
MX - Messico 30
TW - Taiwan 28
EC - Ecuador 22
RO - Romania 22
UZ - Uzbekistan 22
IR - Iran 21
SA - Arabia Saudita 21
CO - Colombia 19
AU - Australia 18
GR - Grecia 17
LT - Lituania 15
IL - Israele 12
TN - Tunisia 12
EG - Egitto 11
MA - Marocco 11
MY - Malesia 11
VE - Venezuela 11
LB - Libano 10
PY - Paraguay 10
UY - Uruguay 10
CL - Cile 9
AE - Emirati Arabi Uniti 8
JM - Giamaica 8
CZ - Repubblica Ceca 7
KE - Kenya 7
PT - Portogallo 7
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
AZ - Azerbaigian 5
BZ - Belize 5
ET - Etiopia 5
LV - Lettonia 5
OM - Oman 5
PE - Perù 5
DK - Danimarca 4
HU - Ungheria 4
MD - Moldavia 4
NP - Nepal 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AM - Armenia 3
CR - Costa Rica 3
CY - Cipro 3
DZ - Algeria 3
GH - Ghana 3
HN - Honduras 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AL - Albania 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
KW - Kuwait 2
Totale 29.224
Salva come PNG Salva come JPEG
Città #
Singapore 1.904
Ashburn 1.109
Southend 1.019
Bologna 844
Chandler 806
Fairfield 712
Hong Kong 560
Santa Clara 547
San Jose 546
Ho Chi Minh City 538
Hefei 511
Hanoi 486
Ann Arbor 415
Houston 411
Woodbridge 318
Dallas 301
Wilmington 291
Boardman 290
Beijing 281
Princeton 267
Seattle 263
Dong Ket 251
Cambridge 229
Dublin 207
Seoul 202
Lomé 194
Milan 192
New York 174
Frankfurt am Main 156
Tokyo 152
Lauterbourg 150
Los Angeles 148
Abidjan 140
Helsinki 127
Council Bluffs 126
Nanjing 118
Padova 115
Jacksonville 111
Westminster 108
Buffalo 97
Berlin 91
Da Nang 87
Sofia 87
Vienna 79
Haiphong 72
Rome 72
Munich 70
Bern 69
Amman 66
Turin 66
Jinan 65
Abeokuta 64
San Diego 64
Redondo Beach 58
Redwood City 56
Brussels 55
Saint Petersburg 55
Johannesburg 52
Florence 51
Chicago 48
Guangzhou 48
São Paulo 48
Changsha 47
London 46
Redmond 46
Medford 44
Shenyang 43
Bengaluru 42
Orem 42
Parma 42
Rimini 41
Shanghai 41
Toronto 41
Amsterdam 40
Moscow 39
Udine 38
Bremen 37
Montreal 36
The Dalles 36
Jakarta 34
Turku 33
Nanchang 32
Lappeenranta 30
Castel Maggiore 28
Falkenstein 28
Nuremberg 28
Verona 28
Des Moines 27
Hebei 27
Modena 27
San Francisco 27
Bangkok 26
Tianjin 26
Falls Church 25
Hải Dương 25
Warsaw 25
Biên Hòa 24
Phoenix 23
Can Tho 22
Dearborn 22
Totale 18.107
Salva come PNG Salva come JPEG
Nome #
Multiple roles of phosphoinositide-specific phospholipase C isozymes. 426
AEducaAR, Anatomical Education in Augmented Reality: A Pilot Experience of an Innovative Educational Tool Combining AR Technology and 3D Printing 390
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 354
Near-peer teaching in human anatomy from a tutors’ perspective: An eighteen-year-old experience at the university of Bologna 292
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia 291
Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H(2)O(2 290
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients 272
Combining prelamin A accumulation and oxidative stress: A strategy to target glioblastoma 271
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes 263
Three-dimensional virtual anatomy as a new approach for medical student’s learning 263
Body donor reperfusion and re-ventilation in medical training: an Italian study testing SimLife® 257
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness 255
Prolonged low-dose azacitidine schedule in high-risk MDS patients: Hematologic and molecular response 254
Inositide-Dependent Nuclear Signalling in Health and Disease 252
Anatomic Cartography of the Hypogastric Nerves and Surgical Insights for Autonomic Preservation during Radical Pelvic Procedures. 248
Endoscopic endonasal anatomy of the ophthalmic artery in the optic canal 245
In vitro reparative dentin: a biochemical and morphological study. 242
A scientific (c)old case at “Luigi Cattaneo” Anatomical Wax Collection in Bologna: solving an intriguing puzzle? 238
Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy 234
Anatomy of the optic canal and its clinical role 234
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS 228
Molecular Characterization of High-Risk MDS Patients Treated with Azacitidine and Lenalidomide: Role of Inositide-Dependent Signalling, Mutations and Microrna 228
Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes 227
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide 225
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 225
Augmented Reality-Assisted Periosteum Pedicled Flap Harvesting for Head and Neck Reconstruction: An Anatomical and Clinical Viability Study of a Galeo-Pericranial Flap 224
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 222
Anatomical Laser Microdissection of the Ileum Reveals mtDNA Depletion Recovery in A Mitochondrial Neuro-Gastrointestinal Encephalomyopathy (MNGIE) Patient Receiving Liver Transplant 220
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES 219
Dissecting human anatomy learning process through anatomical education with augmented reality: AEducAR 2.0, an updated interdisciplinary study 217
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS 217
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes 215
Nuclear inositide signaling and cell cycle 213
Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma 213
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 210
Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes 208
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 207
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia 206
Nuclear Inositide Signaling via Phospholipase C 206
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 206
Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside 204
Endoscopic endonasal approach to primitive Meckel's cave tumors: a clinical series 204
Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia 204
Early Increase of Phospholipase Cbeta1 (PI-PLCbeta1) Gene Expression Predicts Azacitidine Responsiveness in MDS Patients 202
Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression 202
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology 202
The wide and growing range of lamin B‑related diseases: from laminopathies to cancer 199
DIFFERENTIAL EFFECT OF LENALIDOMIDE ON INDUCTION OF INOSITIDE-DEPENDENT ERYTHROPOIESIS AND CELL CYCLE IN MYELODYSPLASTIC SYNDROMES 198
To the Heart of IFs Function: Do they Aggregate on Purpose? 197
Intranuclear 3'-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? 196
Nuclear inositides: facts and perspectives. 194
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 194
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms 193
The whole body donation program at the university of Bologna: A report based on the experience of one of the oldest university in Western world 193
Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders 192
Anatomical variations of the right renal and spermatic arteries: a case report 191
Augmented Reality in Higher Education an Exploratory Study on the Beliefs of Medical Students 190
Anatomical Study of the Application of a Galeo-Pericranial Flap in Oral Cavity Defects Reconstruction 188
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 188
Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) 188
Investigation of human cadavers: one year of anatomic variants and their clinical correlation 188
The anatomy of the pelvic plexus in female cadavers: implications for retroperitoneal nerve-sparing surgery 187
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients 187
Phosphoinositide-dependent signaling in cancer: A focus on phospholipase C isozymes 187
PLA-Based Mineral-Doped Scaffolds Seeded with Human Periapical Cyst-Derived MSCs: A Promising Tool for Regenerative Healing in Dentistry 186
Subcellular localization relevance and cancer-associated mechanisms of diacylglycerol kinases 186
Inositide signaling in the nucleus: From physiology to pathology. 185
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulations of PC12 cells 184
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 184
Unilateral absence of Casserio’s nerve and a communicating branch to the median nerve. An additional variant of brachial flexors motor innervation 184
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 184
Advances in MDS/AML and inositide signalling 183
Regulation of nuclear phospholipase C activity 183
Structural Variants at the LMNB1 Locus: Deciphering Pathomechanisms in Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy 180
Signaling Role of Pericytes in Vascular Health and Tissue Homeostasis 179
Lamin B1 as a key modulator of the developing and aging brain 176
Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia 176
Nuclear phospholipase C beta1 and cellular differentiation. 175
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 175
Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes 174
Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies 173
Hypo and retrotympanum: the importance of anatomical variants 171
Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. 170
The involvement of signaling pathways in the pathogenesis of osteoarthritis: An update 169
Nuclear Phosphoinositides as Key Determinants of Nuclear Functions 169
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE 169
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells 169
Hepato-gastric and spleno-mesenteric arterial trunks: anatomical variation report and review of literature 167
Exploring the controversial role of PI3K signalling in CD4+ regulatory T (T-Reg) cells 166
Anatomical Measurements of the Malar Bone for Safe Zygomatic Implant Placement: A Study on Donated Bodies 165
Nuclear Nox4-Derived Reactive Oxygen Species in Myelodysplastic Syndromes 165
The anatomical wax collection at the University of Bologna: bridging the gap between tradition and scientific innovation 164
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies 163
Epigenetic regulation of nuclear PLCbeta1 and Cyclin D3 during Azacitidine treatment 163
PLC and PI3K/Akt/mTOR signalling in disease and cancer 162
PI-PLCβ1b affects Akt activation, cyclin E expression, and caspase cleavage, promoting cell survival in pro-B-lymphoblastic cells exposed to oxidative stress 162
Phosphoinositide 3 Kinase signaling in human stem cells from reprogramming to differentiation: A tale in cytoplasmic and nuclear compartments 162
Role of inositide signalling regulation in higher-risk MDS patients during epigenetic therapy 161
Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients 160
Epigenetic Regulation of Lipid Signalling Pathways In Low-Risk MDS Patients During Azacitidine Treatment 159
Totale 20.778
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.709
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021552 0 0 0 0 0 0 0 0 0 0 0 552
2021/20223.050 221 56 175 284 241 144 133 187 106 503 530 470
2022/20233.544 341 450 178 523 303 266 223 220 536 62 212 230
2023/20241.464 96 197 139 145 152 207 68 81 100 131 64 84
2024/20254.617 167 527 363 299 672 253 406 203 136 369 323 899
2025/202611.375 922 1.235 1.091 774 1.190 633 1.208 343 2.029 872 598 480
Totale 29.918